Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

December 01, 2019; Volume 96,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adlere, Ilze

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  2. Andersen, Signe

    1. You have access
      Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
  3. Arimont, Marta

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
    3. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

B

  1. Bachelerie, Françoise

    1. You have access
      Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329
  2. Baek, Yi-Yong

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  3. Baker, Jillian G.

    1. You have access
      Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515
  4. Balabanian, Karl

    1. You have access
      Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329
  5. Barrella, Lorenzo

    1. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871
  6. Biggin, Philip C.

    1. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871
  7. Bobkov, Vladimir

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
  8. Briddon, Stephen

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  9. Briddon, Stephen J.

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
  10. Bünemann, Moritz

    1. You have access
      Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515

C

  1. Calhoun, Jacob

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  2. Capoferri, Davide

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
  3. Caspar, Birgit

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
    2. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    3. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  4. Chavez-Abiega, Sergei

    1. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871
  5. Chen, Gang

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881
  6. Chen, Lijuan

    1. You have access
      The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812
  7. Choi, Seunghwan

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

D

  1. de Esch, Iwan

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  2. de Graaf, Chris

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  3. De Groof, Timo W.M.

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
  4. de Haard, Hans

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
  5. Dekkers, Sebastian

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  6. Durroux, Thierry

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

F

  1. Fumagalli, Amos

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      You have access
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

G

  1. Gallego, Carmen

    1. You have access
      Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

H

  1. Ha, Kwon-Soo

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  2. Heasley, Lynn E.

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  3. Heuninck, Joyce

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
  4. Hill, Stephen

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  5. Hill, Stephen J.

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
    2. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
  6. Hinz, Trista K.

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  7. Hoffmann, Carsten

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
    2. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
  8. Hunt, Martina S.

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

I

  1. Işbilir, Ali

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

J

  1. Jackson, William F.

    1. You have access
      Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822
  2. Jeoung, Dooil

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

K

  1. Kellam, Barrie

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  2. Kim, Ji-Yoon

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  3. Kim, Jihye

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  4. Kim, Joohwan

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  5. Kim, Suji

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  6. Kim, Taesam

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  7. Kim, Young-Myeong

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  8. Kleczko, Emily K.

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  9. Koenen, Joyce

    1. You have access
      Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329
  10. Kolb, Peter

    1. You have access
      Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515
  11. Kristensen, Anders S.

    1. You have access
      Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
    2. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871
  12. Kunselman, Jennifer M.

    1. You have access
      Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267
  13. Kwon, Young-Guen

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

L

  1. Ladefoged, Lucy Kate

    1. You have access
      Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
  2. Lazarus, Philip

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881
  3. Lee, Hansoo

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  4. Leurs, Rob

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  5. Li, Yong

    1. You have access
      The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812
  6. Lohse, Martin J.

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

M

  1. Marek, Lindsay A.

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  2. Marin, Philippe

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      You have access
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279
  3. Mayor, Federico

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      You have access
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279
  4. Milligan, Graeme

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
  5. Mohammadi, Mohammadjavad

    1. You have access
      An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176
  6. Munro, Lachlan

    1. You have access
      Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
  7. Musgaard, Maria

    1. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

N

  1. Neubig, Richard R.

    1. You have access
      An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176
    2. You have access
      Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822
  2. Neves, Maria

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      You have access
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279
  3. Niu, Lu

    1. You have access
      The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

P

  1. Padmanathan, Vithushan

    1. You have access
      Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
  2. Park, Minsik

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  3. Park, Wonjin

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234
  4. Perpiñá Viciano, Cristina

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
  5. Phan, Hoa T.N.

    1. You have access
      Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822
  6. Pin, Jean-Philippe

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
  7. Puthenveedu, Manojkumar A.

    1. You have access
      Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267

Q

  1. Quinn, Josiah A.

    1. You have access
      An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176

S

  1. Scharf, Magdalena M.

    1. You have access
      Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515
  2. Schiøtt, Birgit

    1. You have access
      Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
  3. Schlecht-Louf, Géraldine

    1. You have access
      Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329
  4. Shaw, Vincent S.

    1. You have access
      An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176
    2. You have access
      Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822
  5. Shi, Jian

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881
  6. Singleton, Katherine R.

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  7. Smit, Martine J.

    1. You have access
      From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function
      Martine J. Smit and Jacqueline E. van Muijlwijk-Koezen
      Molecular Pharmacology December 2019, 96 (6) 735-736; DOI: https://doi.org/10.1124/mol.119.118364
    2. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    3. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
    4. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      You have access
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279
  8. Stenum-Berg, Charlotte

    1. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871
  9. Stocks, Michael

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  10. Stuijt, Jeffrey

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  11. Sutliff, Aimee K.

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

T

  1. Tan, Aik Choon

    1. You have access
      Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
  2. Thisted, Christine L.

    1. You have access
      Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

V

  1. van den Bor, Jelle

    1. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      You have access
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279
  2. van der Woning, Bas

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
  3. van Muijlwijk-Koezen, Jacqueline E.

    1. You have access
      From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function
      Martine J. Smit and Jacqueline E. van Muijlwijk-Koezen
      Molecular Pharmacology December 2019, 96 (6) 735-736; DOI: https://doi.org/10.1124/mol.119.118364
  4. Vashisth, Harish

    1. You have access
      An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176
  5. Visser, Kirsten

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

W

  1. Watson, Christy J.W.

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881
  2. Watts, Stephanie W.

    1. You have access
      Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822
  3. Weinberg, Zara Y.

    1. You have access
      Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267
  4. Wijtmans, Maikel

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663
  5. Won, Moo-Ho

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

Y

  1. Yan, Wei

    1. You have access
      The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812
  2. Yang, Jianhong

    1. You have access
      The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812
  3. Ye, Haoyu

    1. You have access
      The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812
  4. Yun, Jung-A

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

Z

  1. Zajac, Amanda S.

    1. You have access
      Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267
  2. Zarca, Aurélien

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
  3. Zhu, Hao-Jie

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 96 (6)
Molecular Pharmacology
Vol. 96, Issue 6
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics